Bottom Article Ad

Wednesday, December 15, 2021

Global Inflammatory Bowel Disease Treatment Market to be Driven by Biosimilars in the Forecast Period of 2021-2026

The new report by Expert Market Research titled, ‘Global Inflammatory Bowel Disease Treatment Market Report and Forecast 2021-2026’, gives an in-depth analysis of the global inflammatory bowel disease treatment market, assessing the market based on its segments like drug, disease, end-use, and major regions. The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.

Get a Free Sample Report with Table of Contents:

The key highlights of the report include:

Market Overview (2016-2026)

  • Historical Market Size (2020): USD 16.7 Billion
  • Forecast CAGR (2021-2026): 4.5%
  • Forecast Market Size (2026): USD 22 Billion

The global inflammatory bowel disease treatment market is expanding due to factors such as the rising prevalence of Crohn's disease and ulcerative colitis, increased government funding for inflammatory bowel disease studies, and medical technology advancements. In addition, the growing popularity of pre-biotic and pro-biotic food products, as well as a rising number of drugs in clinical trials, are likely to contribute to market growth during the assessment period.

Industry Definition and Major Segments

IBD refers to a category of inflammatory disorders that affect the colon and small intestine. The two most common forms of inflammatory bowel disease are Crohn's disease and ulcerative colitis. The treatment of the disease is known as inflammatory bowel disease treatment.

Read Full Report with Table of Contents:

Based on drug, the market can be divided into:

  • Aminosalicylates
  • Antibiotics
  • Corticosteroids
  • Immunomodulators
  • Biologics
  • Others

Based on disease, the market is divided into:

  • Ulcerative Colitis
  • Crohn's Disease
  • Indeterminate Colitis

The market can be categorised based on end-use into:

  • Fertility Centres
  • Hospitals and Surgical Clinics
  • Research Institutes
  • Cryobanks

Regionally, the industry is classified into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Market Trends

Rising demand for effective treatment has been driving the growth of the industry. Janssen Biotech Inc. and Protagonist Therapeutics Inc. signed a strategic agreement in 2017 to produce, manufacture, and market PTG-200, an oral IL 23 receptor for the treatment of inflammatory bowel disease. In another case, the European Union granted Pfizer Inc. marketing authorization for XELJANZ in 2018 for the treatment of moderate to serious ulcerative colitis.

Key Market Players

The major players in the market are Abbott Laboratories, Biocon Ltd., F. Hoffmann-La Roche Ag, Johnson & Johnson, Mylan Pharmaceuticals Ltd., Novartis Ag, Pfizer Inc., Quest Medical Inc., Sanofi S.A., and Takeda Pharmaceutical Company Ltd. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.

About Us:

Expert Market Research is a leading business intelligence firm, providing custom and syndicated market reports along with consultancy services for our clients. We serve a wide client base ranging from Fortune 1000 companies to small and medium enterprises. Our reports cover over 100 industries across established and emerging markets researched by our skilled analysts who track the latest economic, demographic, trade and market data globally.

At Expert Market Research, we tailor our approach according to our clients’ needs and preferences, providing them with valuable, actionable and up-to-date insights into the market, thus, helping them realize their optimum growth potential. We offer market intelligence across a range of industry verticals which include Pharmaceuticals, Food and Beverage, Technology, Retail, Chemical and Materials, Energy and Mining, Packaging and Agriculture.

Media Contact

Company Name: EMR Inc.
Contact Person:-Ian Bell, Business Consultant
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
City: Sheridan
State: Wyoming
Country: United States

Read More Reports:

Global Microencapsulation Market:

Global Anti-Infectives Market:

Global Liposomal Doxorubicin Market:

Global Infertility Drugs Market:

Global Contraceptive Drugs Market:

Explore more on Procurement Intelligence services of EMR Inc.

Also visit:

**We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.


Post a Comment